These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25298354)

  • 1. [The Symplicity HTN-3 study].
    Taddei S; Trabattoni D
    G Ital Cardiol (Rome); 2014 Sep; 15(9):460-4. PubMed ID: 25298354
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2013 Oct; 22(5):279-81. PubMed ID: 24059787
    [No Abstract]   [Full Text] [Related]  

  • 3. SYMPLICITY HTN-3 trial: what is it and what does it mean?
    Böhm M; Mahfoud F
    Eur Heart J; 2014 Jul; 35(26):1697-8. PubMed ID: 25152948
    [No Abstract]   [Full Text] [Related]  

  • 4. Was there real denervation in the SYMPLICITY HTN-3 trial?
    Ruilope LM
    Eur Heart J; 2014 Jul; 35(26):1699-1700. PubMed ID: 25152949
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials.
    Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
    Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal sympathetic denervation in the aftermath of Symplicity HTN-3.
    Kjeldsen SE; Fadl Elmula FE; Persu A; Jin Y; Staessen JA
    Blood Press; 2014 Oct; 23(5):256-61. PubMed ID: 25212427
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistant hypertension and renal denervation. Considerations on the results of the SYMPLICITY HTN-3 trial.
    Ruilope LM; Arribas F
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):881-2. PubMed ID: 25242659
    [No Abstract]   [Full Text] [Related]  

  • 8. SYMPLICITY: not all that simple.
    Luft FC
    Kidney Int; 2014 May; 85(5):999-1001. PubMed ID: 24786869
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
    Lüscher TF; Mahfoud F
    Eur Heart J; 2014 Jul; 35(26):1706-11. PubMed ID: 24829361
    [No Abstract]   [Full Text] [Related]  

  • 10. [Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].
    Azpiri-López JR; Assad-Morell JL; Ponce de León-Martínez E; Monreal-Puente R; Dávila-Bortoni A; Vázquez-Díaz LA; Treviño-Frutos RJ; Barrera-Oranday F; Del Angel-Soto JG; Martínez JG; Arellano-Torres M
    Arch Cardiol Mex; 2015; 85(2):154-7. PubMed ID: 25700579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'SYMPLICITY: not all that simple' is, in fact, simple.
    Meltzer J; Oliver J
    Kidney Int; 2014 Nov; 86(5):1060. PubMed ID: 25360502
    [No Abstract]   [Full Text] [Related]  

  • 12. New analysis of the SYMPLICITY HTN-3 trial.
    Mason E; Tofield A
    Eur Heart J; 2015 Mar; 36(9):535. PubMed ID: 25884066
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal sympathetic denervation for refractory hypertension.
    Bunte MC
    Lancet; 2011 Mar; 377(9771):1074; author reply 1074-5. PubMed ID: 21440803
    [No Abstract]   [Full Text] [Related]  

  • 14. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?
    Pathak A; Ewen S; Fajadet J; Honton B; Mahfoud F; Marco J; Schlaich M; Schmieder R; Tsioufis K; Ukena C; Zeller T
    EuroIntervention; 2014 May; 10(1):21-3. PubMed ID: 24832632
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal sympathetic denervation: hypertension therapy and beyond.
    Williams PD; Whitbourn R
    Expert Rev Med Devices; 2013 May; 10(3):329-38. PubMed ID: 23668705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
    Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?
    Schmieder RE
    Nat Rev Cardiol; 2014 Jul; 11(7):375-6. PubMed ID: 24839974
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in renal denervation.
    Raphael CE; Davies JE
    Minerva Cardioangiol; 2013 Jun; 61(3):271-80. PubMed ID: 23681130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic denervation for treatment resistant hypertension.
    Kok HK; Wong L; Loo B; Torreggiani WC
    Ir Med J; 2013 Jan; 106(1):5-6. PubMed ID: 23472366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.